Coldstream Capital Management’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $200K | Buy |
7,253
+2,039
| +39% | +$56.3K | ﹤0.01% | 1072 |
|
|
2025
Q1 | $148K | Buy |
5,214
+165
| +3% | +$4.68K | ﹤0.01% | 1153 |
|
|
2024
Q4 | $210K | Buy |
5,049
+1,440
| +40% | +$59.9K | ﹤0.01% | 991 |
|
|
2024
Q3 | $236K | Sell |
3,609
-745
| -17% | -$48.7K | 0.01% | 963 |
|
|
2024
Q2 | $517K | Buy |
4,354
+1,011
| +30% | +$120K | 0.01% | 536 |
|
|
2024
Q1 | $356K | Buy |
3,343
+675
| +25% | +$71.9K | 0.01% | 689 |
|
|
2023
Q4 | $265K | Sell |
2,668
-867
| -25% | -$86.2K | 0.01% | 758 |
|
|
2023
Q3 | $365K | Buy |
3,535
+77
| +2% | +$7.95K | 0.01% | 542 |
|
|
2023
Q2 | $420K | Sell |
3,458
-251
| -7% | -$30.5K | 0.01% | 503 |
|
|
2023
Q1 | $570K | Sell |
3,709
-465
| -11% | -$71.4K | 0.02% | 394 |
|
|
2022
Q4 | $750K | Buy |
+4,174
| New | +$750K | 0.03% | 316 |
|
|
2022
Q2 | $496K | Buy |
3,469
+638
| +23% | +$91.2K | 0.02% | 392 |
|
|
2022
Q1 | $488K | Buy |
2,831
+49
| +2% | +$8.45K | 0.02% | 393 |
|
|
2021
Q4 | $707K | Buy |
+2,782
| New | +$707K | 0.02% | 309 |
|
|
2021
Q3 | – | Sell |
-1,209
| Closed | -$284K | – | 496 |
|
|
2021
Q2 | $284K | Buy |
+1,209
| New | +$284K | 0.01% | 403 |
|